• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Health Insurance Innovations acquires direct-to-consumer platform

Share:

June 10, 2019

Health Insurance Innovations (NASDAQ:HIIQ) has acquired TogetherHealth, a direct-to-consumer platform aimed at the “over 65” insurance market.

Under the terms of the deal, HIIQ paid ~$50M in cash plus 630K shares of Class A common stock. It also included a five-year earnout provision.

The transaction will add at least $10M to HIIQ’s 2019 non-GAAP EBITDA.

Updated 2019 guidance: revenues: $450M – 460M from $430M – 440M; non-GAAP EBITDA: $82M – 87M from $72M – 77M; non-GAAP EPS: $3.80 – 4.05 from $3.50 – 3.75.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The company has established a new $215M credit facility that includes a $150M term loan and a $65M revolver. The term loan will fund the refinancing of $65M of existing debt and the cash portion of the transaction.

Management will host a conference call this morning at 9:00 am ET to discuss the deal.

Shares are up 6% premarket on light volume.

Date: June 10, 2019

Source: AwesomeCapital

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Icario Acquires Consumer Engagement and Health Action Platform ChipRewardsIcario Acquires Consumer Engagement and Health Action Platform ChipRewards
  • Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of Its Innovative Synthetic VaccinesDelonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of Its Innovative Synthetic Vaccines
  • ACTO Closes $11.5M Series A Round to Accelerate Virtual Transformation for Life Sciences CompaniesACTO Closes $11.5M Series A Round to Accelerate Virtual Transformation for Life Sciences Companies
  • Envision US$9.9bn leveraged buyout by KKR adds to private equity deal bonanzaEnvision US$9.9bn leveraged buyout by KKR adds to private equity deal bonanza
  • Biotherapeutics Startup Hummingbird Raises US$19M in Series B FundingBiotherapeutics Startup Hummingbird Raises US$19M in Series B Funding
  • Israeli-Italian Collaboration to Study the Behaviour of Antibacterial Materials in SpaceIsraeli-Italian Collaboration to Study the Behaviour of Antibacterial Materials in Space
  • Scilex Holding Company, a Sorrento Company, has Entered a Term Sheet to Acquire Ancora Medical Inc.Scilex Holding Company, a Sorrento Company, has Entered a Term Sheet to Acquire Ancora Medical Inc.
  • Glaxo, Pfizer to merge consumer health care divisionsGlaxo, Pfizer to merge consumer health care divisions

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications